Dados do Trabalho

Título

CLINICAL AND ULTRASONOGRAPHIC EVALUATION OF DYSPHAGIA IN PATIENTS WITH LAMA2-CMD

Introdução

LAMA2-CMD is a rare autosomal recessive disease characterized by hypotonia, muscle weakness, and the inability to achieve independent gait. It imposes a considerable disease burden, including difficulty in weight gain and dysphagia.

Objetivo

Assess the disease burden of dysphagia in the LAMA2-RD patients

Método

Patients with genetically confirmed LAMA2-CMD were cross-sectionally evaluated. Clinical assessments included analysis of dysphagia, NdSss scale, weight measurement, and the necessity of gastrostomy. Patients received ultrasound evaluations of tongue muscles, and the muscle abnormalities were classified using the modified Heckmatt scale. The ultrasound M mode assessed the hyoid elevation movement during swallowing.
Qualitative analysis of ultrasound findings and correlations with clinical presentations were conducted.

Resultados

20 patients with LAMA2-CMD were evaluated, ranging from 3-27 years old (mean 7.7). 8/20 patients (40%) weighted below the 3rd percentile. All patients experienced some degree of dysphagia, with a maximum score of 7 on the NdSss scale. 17/20 patients (85%) reported taking over 30 minutes to finish a meal. 4/20 patients (20%) had gastrostomy tubes. The geniohyoid muscle was the most affected among the three tongue muscles evaluated. 14/ 20 patients had markedly hyperechoic muscle. The genioglossus muscle was the second most affected, with 9/20 patients having markedly hyperechoic muscle. None of the patients had normal geniohyoid or genioglossus muscles. Lastly, the least affected muscle was the digastric, with 7/20 patients having markedly hyperechoic muscle. 16/20 patients required an increased number of hyoid elevation movements and had low amplitude movements during swallowing.
A correlation was observed between the patient's age and the severity of ultrasound abnormalities. The genioglossus and geniohyoid muscles appeared more preserved in patients under 5 years old than older patients (p=0.005 and p=0.017, respectively). Similarly, there was a correlation between extremely low weight (P<3) and markedly hyperechoic genioglossus muscle (p=0.0176).

Conclusão

Patients with LAMA2-CMD experience greater difficulty in weight gain and exhibit some degree of dysphagia. Assessing tongue muscles via ultrasound is a valuable tool for comprehending functional abnormalities in these patients, aiding in clinical management, and potentially serving as a marker for disease progression.

Referências

1. Bonnemann CG, Wang CH, Quijano-Roy S, Deconinck N, Bertini E, Ferreiro A, et al. Diagnostic approach to the congenital muscular dystrophies. Neuromuscul Disord. 2014;24(4):289-311.
2. Tome FM, Evangelista T, Leclerc A, Sunada Y, Manole E, Estournet B, et al. Congenital muscular dystrophy with merosin deficiency. C R Acad Sci III. 1994;317(4):351-7.
3. Reed UC. Congenital muscular dystrophy. Part I: a review of phenotypical and diagnostic aspects. Arq Neuropsiquiatr. 2009;67(1):144-68.
4. Oliveira J, Santos R, Soares-Silva I, Jorge P, Vieira E, Oliveira ME, et al. LAMA2 gene analysis in a cohort of 26 congenital muscular dystrophy patients. Clin Genet. 2008;74(6):502-12.
5. Oliveira J, Parente Freixo J, Santos M, Coelho T. LAMA2 Muscular Dystrophy. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, et al., editors. GeneReviews((R)). Seattle (WA)1993.
6. Geranmayeh F, Clement E, Feng LH, Sewry C, Pagan J, Mein R, et al. Genotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations. Neuromuscul Disord. 2010;20(4):241-50.
7. Zambon AA, Ridout D, Main M, Mein R, Phadke R, Muntoni F, et al. LAMA2-related muscular dystrophy: Natural history of a large pediatric cohort. Ann Clin Transl Neurol. 2020;7(10):1870-82.
8. Tan D, Ge L, Fan Y, Chang X, Wang S, Wei C, et al. Natural history and genetic study of LAMA2-related muscular dystrophy in a large Chinese cohort. Orphanet J Rare Dis. 2021;16(1):319.
9. Vuillerot C, Rippert P, Kinet V, Renders A, Jain M, Waite M, et al. Rasch analysis of the motor function measure in patients with congenital muscle dystrophy and congenital myopathy. Arch Phys Med Rehabil. 2014;95(11):2086-95.
10. Meilleur KG, Jain MS, Hynan LS, Shieh CY, Kim E, Waite M, et al. Results of a two-year pilot study of clinical outcome measures in collagen VI- and laminin alpha2-related congenital muscular dystrophies. Neuromuscul Disord. 2015;25(1):43-54.
11. Trundell D, Le Scouiller S, Gorni K, Seabrook T, Vuillerot C, Group SMS. Validity and Reliability of the 32-Item Motor Function Measure in 2- to 5-Year-Olds with Neuromuscular Disorders and 2- to 25-Year-Olds with Spinal Muscular Atrophy. Neurol Ther. 2020;9(2):575-84.
12. Mazzone ES, Mayhew A, Montes J, Ramsey D, Fanelli L, Young SD, et al. Revised upper limb module for spinal muscular atrophy: Development of a new module. Muscle Nerve. 2017;55(6):869-74.
13. Jain MS, Meilleur K, Kim E, Norato G, Waite M, Nelson L, et al. Longitudinal changes in clinical outcome measures in COL6-related dystrophies and LAMA2-related dystrophies. Neurology. 2019;93(21):e1932-e43.

Palavras Chave

LAMA2; Congenital Muscular Dystrophy; Dysphagia